Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]

Guardado en:

Detalles Bibliográficos
Autores principales:	Vinicius Fontanesi Blum, MD, MSc, Sérgio Cimerman, MD, PhD, James R Hunter, PhD, Paulo Tierno, MD, Acioly Lacerda, Alexandre Soeiro, MD, Florentino Cardoso, MD, Nancy Cristina Bellei, PhD, MD, Juliana Maricato, PhD, Nathalia Mantovani, PhD, Marcella Vassao, MSc, Danilo Dias, Juliana Galinskas, Luis Mário Ramos Janini, MD, PhD, Joanna Reis Santos-Oliveira, PhD, Alda Maria Da-Cruz, MD, PhD, Ricardo Sobhie Diaz, MD, PhD
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/3db21fa89b734dc4a519f9cfbdb17eb7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:3db21fa89b734dc4a519f9cfbdb17eb7
record_format	dspace
spelling	oai:doaj.org-article:3db21fa89b734dc4a519f9cfbdb17eb72021-11-16T04:11:04ZCorrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]2589-537010.1016/j.eclinm.2021.101203https://doaj.org/article/3db21fa89b734dc4a519f9cfbdb17eb72021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2589537021004843https://doaj.org/toc/2589-5370Vinicius Fontanesi Blum, MD, MScSérgio Cimerman, MD, PhDJames R Hunter, PhDPaulo Tierno, MDAcioly LacerdaAlexandre Soeiro, MDFlorentino Cardoso, MDNancy Cristina Bellei, PhD, MDJuliana Maricato, PhDNathalia Mantovani, PhDMarcella Vassao, MScDanilo DiasJuliana GalinskasLuis Mário Ramos Janini, MD, PhDJoanna Reis Santos-Oliveira, PhDAlda Maria Da-Cruz, MD, PhDRicardo Sobhie Diaz, MD, PhDElsevierarticleMedicine (General)R5-920ENEClinicalMedicine, Vol 41, Iss , Pp 101203- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Vinicius Fontanesi Blum, MD, MSc Sérgio Cimerman, MD, PhD James R Hunter, PhD Paulo Tierno, MD Acioly Lacerda Alexandre Soeiro, MD Florentino Cardoso, MD Nancy Cristina Bellei, PhD, MD Juliana Maricato, PhD Nathalia Mantovani, PhD Marcella Vassao, MSc Danilo Dias Juliana Galinskas Luis Mário Ramos Janini, MD, PhD Joanna Reis Santos-Oliveira, PhD Alda Maria Da-Cruz, MD, PhD Ricardo Sobhie Diaz, MD, PhD Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
format	article
author	Vinicius Fontanesi Blum, MD, MSc Sérgio Cimerman, MD, PhD James R Hunter, PhD Paulo Tierno, MD Acioly Lacerda Alexandre Soeiro, MD Florentino Cardoso, MD Nancy Cristina Bellei, PhD, MD Juliana Maricato, PhD Nathalia Mantovani, PhD Marcella Vassao, MSc Danilo Dias Juliana Galinskas Luis Mário Ramos Janini, MD, PhD Joanna Reis Santos-Oliveira, PhD Alda Maria Da-Cruz, MD, PhD Ricardo Sobhie Diaz, MD, PhD
author_facet	Vinicius Fontanesi Blum, MD, MSc Sérgio Cimerman, MD, PhD James R Hunter, PhD Paulo Tierno, MD Acioly Lacerda Alexandre Soeiro, MD Florentino Cardoso, MD Nancy Cristina Bellei, PhD, MD Juliana Maricato, PhD Nathalia Mantovani, PhD Marcella Vassao, MSc Danilo Dias Juliana Galinskas Luis Mário Ramos Janini, MD, PhD Joanna Reis Santos-Oliveira, PhD Alda Maria Da-Cruz, MD, PhD Ricardo Sobhie Diaz, MD, PhD
author_sort	Vinicius Fontanesi Blum, MD, MSc
title	Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
title_short	Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
title_full	Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
title_fullStr	Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
title_full_unstemmed	Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
title_sort	corrigendum to “nitazoxanide superiority to placebo to treat moderate covid-19 – a pilot prove of concept randomized double-blind clinical trial.” [eclinicalmedicine 37 (2021) 100981]
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/3db21fa89b734dc4a519f9cfbdb17eb7
work_keys_str_mv	AT viniciusfontanesiblummdmsc corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT sergiocimermanmdphd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT jamesrhunterphd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT paulotiernomd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT aciolylacerda corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT alexandresoeiromd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT florentinocardosomd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT nancycristinabelleiphdmd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT julianamaricatophd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT nathaliamantovaniphd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT marcellavassaomsc corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT danilodias corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT julianagalinskas corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT luismarioramosjaninimdphd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT joannareissantosoliveiraphd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT aldamariadacruzmdphd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT ricardosobhiediazmdphd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981
_version_	1718426718685888512

Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]

Ejemplares similares